EFFECT OF RIBAVIRIN ON TYPE 2 HERPESVIRUS HOMINIS (HVH/2) IN VITRO AND IN VIVO
- 1 May 1977
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 284 (1), 247-253
- https://doi.org/10.1111/j.1749-6632.1977.tb21957.x
Abstract
Ribavirin was found to inhibit five strains of HVH/2 tested in KB cells with the M1C range being 10-100 microgram/ml. In a mouse tail animal model, it effectively reduced HVH/2-induced lesions particularly at the peak lesion periods. Ribavirin was remarkably effective when intravaginal treatment was initiated late in the infection, which suggests that it may have potential for treatment of human cutaneous infections.This publication has 11 references indexed in Scilit:
- Resistance to Herpes Simplex Type 2 Virus Induced by an Immunopotentiator (Pyran) in Immunosuppressed MiceThe Journal of Immunology, 1975
- Genital herpesvirus hominis infection in mice. I. Development of an experimental modelInfection and Immunity, 1975
- Infection with Herpes-Simplex Viruses 1 and 2New England Journal of Medicine, 1973
- Effect of 1-β- d -Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Herpes and Vaccinia Keratitis and Encephalitis in Laboratory AnimalsAntimicrobial Agents and Chemotherapy, 1973
- In Vitro Effect of 1-β- d -Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Deoxyribonucleic Acid and Ribonucleic Acid VirusesAntimicrobial Agents and Chemotherapy, 1973
- Design, synthesis, and broad spectrum antiviral activity of 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosidesJournal of Medicinal Chemistry, 1972
- Use of Disposable Micro Tissue Culture Plates for Antiviral and Interferon Induction StudiesApplied Microbiology, 1971
- 36 Experimental Genital Herpes Simplex infection in the MousePediatric Research, 1967